Neurelis, Inc. Report issue

For profit Phase 2 Phase 3
Founded: Encinatas CA United States (2007)

Organization Overview

First Clinical Trial
2011
NCT01364558
First Marketed Drug
2020
diazepam (valium)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

NEURALIS s.a. | Neurelis, Inc. | NEURELIS INC